Thank you for those questions. I’ll deal with your last point first, on reciprocal healthcare arrangements. Between the different Governments in the United Kingdom, I think there’s an agreement that we want reciprocal healthcare arrangements to continue. The challenge still is having a piece of legislation that we all can support. At present—you’ll have seen the report on this, it's a draft report or a final report from the Health, Social Care and Sport Committee, where I’m not currently in a position to recommend to the Assembly that we give legislative consent. So, that’s about the drafting of the current piece of legislation and the powers the UK Government seem to take, which I think are well beyond what is necessary to make sure that those arrangements remain in place. If there is no deal and there is no alternative legislation in place, then potentially those arrangements fall away, and that obviously affects European Union nationals in the UK, as well as UK nationals within the European Union and the wider European economic area. I will, of course, update Members when there is any further progress on the Bill, and when, I hope, amendments are laid within Parliament that we can support to resolve the issue.

On your point about data and the social care workforce, that’s what we’re looking to have covered by the Ipsos MORI research, so that we understand the range of risks that we are potentially carrying, but also, of course, there is the broader point about wanting to make sure that European Union citizens feel generally welcomed here in Wales and have a Government that is on their side. A number of workers across health and care have already voted with their feet and left, with the changing environment that exists. It is part of our job to make sure those people understand that there is a Government here in Wales that wants them to continue, not just to work and provide services, but actually to live as part of the communities of Wales.

On your broader point about clinical trials, this is something that goes across a range of areas, including higher education. It goes across some of the challenges on attracting and keeping staff within our higher education and our healthcare systems, but also on data sharing as well across different borders. And the challenge here is that much of the data sharing that we have is overseen by a range of data protection Orders, and there is a role for the European Court of Justice in overseeing a range of that information, including, of course, on the broader point about public health data sharing as well, so that we actually have proper disease resilience and intelligence across the European Union. Now, that's part of the challenge of red lines, because if there is absolutely no role for the European Court of Justice, it has a much wider impact than simply keeping some people happy on a limited range of areas; it has a significant impact across health, social care and many wider areas as well. 

On your point about additional funding for medicine supplies, that is a UK Government responsibility. We expect them to be good for the pledges they have already made about funding additional costs for medicines supply if that is necessary. Matt Hancock, the UK Government health Secretary, has said he is now the largest purchaser of fridges in the United Kingdom, so they are already purchasing and acquiring a range of stock. Because the 'no deal' Brexit has moved closer, every Government within the United Kingdom is not just spending time and the resource that we can't use in other areas, we're actually spending money, real cash on preparing for a 'no deal' Brexit that may not happen. That is part of our difficulty. We are spending money that we may not always be able to recover or make use of in a different way. So, I hope people do understand the seriousness of this issue for the country, but also for every Government within the United Kingdom and our use of public money on behalf of the people that we serve.